In 12 months, the Cancer Moonshot has made great strides, secured $1.8 billion in funding and seeded countless projects, partnerships, and possibilities. One year on, a new administration has the power to undo it all.
Gritstone Oncology launched in late 2015, with a $102 million Series A that hinted at some lofty goals for cancer immunotherapy. Some 18-months later, it's presenting the first of its data at the American Association for Cancer Research (AACR) annual meeting.
Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.